Company ProfilePremium

Pelagia AS

Company Profile Analysis

ESOMAR 23 Corporate BadgeISO Certifications Badge
Pelagia AS - Food & Beverages showcase

Year Founded & Workforce

2014

710 Employees

Industry

Food & Beverages

Services

Global Fish Protein Hydrolysate Market
P

Pelagia AS Employee Contacts

25 verified contactsNames, job titles, seniority and locations

View Employee Contacts

Pelagia AS Overview

Company Headquarters: Bergen, Norway

Founded: 2014

Workforce: ~710

Company Working: Pelagia AS is a key producer of various fish-based products for the consumption of humans. The company also supplies essential ingredients such as fishmeal, fish oil, and protein concentrates. Pelagia is also a key producer of concentrated marine-based omega-3 fatty acids to produce pharmaceutical and nutraceutical products along with dietary supplements. The company has several processing plants for fish. Pelagia operates in 28 departments of Norway, Denmark, Ireland, the UK, and Ukraine, among them, 25% are fully owned by Pelagia and the three are partially owned by the company. The operation of the Pelagia is categorized into food, feed, and health.

Strategy

Pelagia AS is focusing on the development of its business through acquisition and strategic collaborations. The company is also focusing on investment strategies for the further development of its marine ingredients-based product portfolio.

Company Snapshot

$1,028.5M

Revenue

710

Employees

2014

Founded

Bergen, Norway

Headquarters

SWOT Analysis

Strengths

  • The increased focus of the company based on ongoing trends such as health and wellness along with new product launches are the key strengths of the company
  • State-of-art production technology

Weaknesses

  • The company is not able to tackle the challenges that occurred owing to new entrants

Opportunities

  • More focus on online channels
  • New trends associated with consumers' preferences and inclination
  • Adoption of new technology standards

Threats

  • Surging rivalry from various global players
  • Shifting consumers' buying pattern

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateApproachDevelopment
December 2017AcquisitionPelagia announced the acquisition of Epax- a foremost brand of concentrated marine-based omega-3 fatty acids for the formulation of pharmaceuticals and nutraceutical products such as dietary supplements.

Product Offering

  • Pelagia AS
    • Global Fish Protein Hydrolysate Market

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

By Business Segment: Sales rose from USD 1,028.5 Mn in 2020 to USD 1,119.2 Mn in 2021.
Pelagia AS — By Business Segment
Series (USD Mn)20202021
Sales1,028.51,119.2

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.